Fundraising FoxAbelZeta Pharma
1 known investors
Find your way into AbelZeta Pharma
Sign up to see every warm intro you have to AbelZeta Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AbelZeta Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AbelZeta develops T cell immunotherapies, advancing pipeline drug candidates through early-stage and investigator-initiated clinical trials to treat cancer and immune and inflammatory (I&I) diseases. The company runs an in-house platform for cell therapy development and partners with global pharmaceutical firms for clinical development and commercialization.
Investors · 1
Frequently asked questions
- What does AbelZeta Pharma do?
- AbelZeta develops T cell immunotherapies, advancing pipeline drug candidates through early-stage and investigator-initiated clinical trials to treat cancer and immune and inflammatory (I&I) diseases. The company runs an in-house platform for cell therapy development and partners with global pharmaceutical firms for clinical development and commercialization.
- Who are AbelZeta Pharma's investors?
- AbelZeta Pharma's investors include HongShan Capital Group.